These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36228878)

  • 1. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
    Itano N; Iwamoto S
    Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 3. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
    Phillips RM; Lam C; Wang H; Tran PT
    Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
    Saeui CT; Shah SR; Fernandez-Gil BI; Zhang C; Agatemor C; Dammen-Brower K; Mathew MP; Buettner M; Gowda P; Khare P; Otamendi-Lopez A; Yang S; Zhang H; Le A; Quinoñes-Hinojosa A; Yarema KJ
    ACS Chem Biol; 2023 Jan; 18(1):151-165. PubMed ID: 36626752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
    Akella NM; Ciraku L; Reginato MJ
    BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hexosamine Biosynthesis Pathway: Regulation and Function.
    Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
    Lam C; Low JY; Tran PT; Wang H
    Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
    Hanover JA; Chen W; Bond MR
    J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights: A role for O-GlcNAcylation in diabetic complications.
    Peterson SB; Hart GW
    Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
    Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
    Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
    Le Minh G; Reginato MJ
    Adv Cancer Res; 2023; 157():195-228. PubMed ID: 36725109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexosamines, insulin resistance, and the complications of diabetes: current status.
    Buse MG
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
    Marsh SA; Dell'Italia LJ; Chatham JC
    Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
    Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
    PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.
    Moloughney JG; Vega-Cotto NM; Liu S; Patel C; Kim PK; Wu CC; Albaciete D; Magaway C; Chang A; Rajput S; Su X; Werlen G; Jacinto E
    J Biol Chem; 2018 Oct; 293(42):16464-16478. PubMed ID: 30201609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer metabolism: cross talk between signaling and O-GlcNAcylation.
    Ferrer CM; Reginato MJ
    Methods Mol Biol; 2014; 1176():73-88. PubMed ID: 25030920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexosamine biosynthetic pathway and
    Kim DY; Park J; Han IO
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.